SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast

Bulletin Express

Aug 05

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.

Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.

Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1188136923"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188136923\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188136923?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188136923","market":"hk","top_or_hot":-1,"title":"SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast","media":"Bulletin Express","content":"<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.</p>\n<p>Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.</p>\n<p>Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.</p>\n<p>Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.</p>\n<p>Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物","start_time":0,"source_url":"","article_id":"1188136923","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188136923","pubTimestamp":1785919828,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物"},"translate_title":"SKB BIO 定于 2026 年 8 月 17 日召开董事会会议，批准 26 年上半年中期业绩；宣布当天网络广播","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":1},"content_text":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.\nFollowing the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.\nBoard composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}